Advances in the Field

May 31, 2017 – (Novartis) – The results, which will be presented at the upcoming 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO; abstract #7509; Monday, June 5, 1:15 PM CDT), that eight of nine evaluable patients had no signs of CLL in their bone marrow at three months.
January 12, 2017 – (TSRI) – “This cellular clock needs to be finely tuned to allow sufficient cell divisions to develop differentiated tissues and maintain renewable tissues in our body and, at the same time, to limit the proliferation of cancerous cells," said TSRI Associate Professor Eros Lazzerini Denchi, corresponding author of the new study.
January 17, 2017 – (Mass General) – Massachusetts General Hospital investigators have found new evidence that the tumor necrosis factor receptor type II may be a major target for immuno-oncology treatments, which induce a patient’s immune system to fight cancer.
January 16, 2017 – (Irvine Scientific) – Irvine Scientific announced the introduction of PRIME-XV T Cell CDM, the first commercially available chemically-defined, animal component-free medium for T cell culture. 
January 16, 2017 – (Fred Hutch) – Researchers have developed a new technique that allows them to examine huge amounts of information from a single cell or zoom out and see data patterns among thousands upon thousands of cells — all in a single experiment.
January 12, 2017 – (Buck Institute) – Buck scientists restore long-term vision in blind mice, making a case for addressing the immune system’s role in rejecting transplanted cells.
January 13, 2017 – (UC Berkley) – Researchers from UC Berkeley have found a way to reprogram mouse embryonic stem cells so that they exhibit developmental characteristics resembling those of fertilized eggs, or zygotes.Scientists Reprogram Embryonic Stem Cells to Expand Their Potential